Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-08-12 09:08:46 - browse：62

Paul Berggreen, a gastroenterologist at Arizona Digestive Health who formed a new lobbying group for independent physician practices. Arizona Digestive Health/ GI Alliance

Private equity gets a bad rap in health care. But some doctors see that kind of cash and consolidation as the only way for their practices to survive — and now, they’re taking that message to Washington.

Lower pay, difficult negotiations with insurance companies, regulatory requirements from both government and commercial payers, expensive and inefficient IT systems, and the challenge of competing against hospital systems have created a “cascade of problems that seem like they are almost insurmountable” for independent practices, said Paul Berggreen, a gastroenterologist at Arizona Digestive Health.

Berggreen is joining with other doctors to start a lobbying group for private practices, the brand-new American Independent Medical Practice Association, or AIMPA, to fight against those problems and advocate for private practice physicians.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Being 'nonadherent' patient made me a more empathetic doctor

focus

WSS

A single drug, study failures leave Anavex with nothing but cash

Beware reading your test results before your doctor does

Goldman Sachs launches $650M fund for life science investments

Fatty liver disease was alleviated by Lilly’s ‘triple

Ahead of JPM, here's who's profiting most in health care

Skip the lead apron during X

focus

Wikipedia

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

AstraZeneca lung cancer study comes in below expectations

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Use doctors trained outside the U.S. to ease the physician shortage

Anesthesiologist group: stop taking Ozempic before surgery

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Duchenne breakthrough therapy leaves behind pioneering families

STAT wants to know your pick for a great summer read or listen

Medicare details structure of new drug price negotiation program

Vertex cell therapy lets patients with type 1 diabetes stop insulin

focus

UCB departs biotech trade group BIO

Drug cartel violence flares in western Mexico after vigilante leader's killing

Federal weight loss drug coverage is 30 years out of date

Dexcom's push to bring CGM to type 2 diabetes patients

Vertex cell therapy lets patients with type 1 diabetes stop insulin

The wait for US passports is creating travel purgatory and snarling summer plans

focus

entertainment

knowledge

focus